CN Patent

CN111393363B — 4-苯氧基喹啉并n-磺酰脒类化合物及其制备方法和用途

Assigned to Weihai Marine Biological Medicine Industry Technology Research Institute Co ltd · Expires 2022-12-20 · 3y expired

What this patent protects

本发明涉及一种4‑苯氧基喹啉并N‑磺酰脒类化合物I，该4‑苯氧基喹啉并N‑磺酰脒类化合物I作为酪氨酸激酶抑制剂，特别是c‑Met抑制剂。本发明还涉及该类化合物的制备方法；本发明更涉及含有4‑苯氧基喹啉并N‑磺酰脒类化合物I作为药物用以治疗与酪氨酸激酶c‑Met相关的疾病，特别是c‑Met相关的癌症的用途。

USPTO Abstract

本发明涉及一种4‑苯氧基喹啉并N‑磺酰脒类化合物I，该4‑苯氧基喹啉并N‑磺酰脒类化合物I作为酪氨酸激酶抑制剂，特别是c‑Met抑制剂。本发明还涉及该类化合物的制备方法；本发明更涉及含有4‑苯氧基喹啉并N‑磺酰脒类化合物I作为药物用以治疗与酪氨酸激酶c‑Met相关的疾病，特别是c‑Met相关的癌症的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN111393363B
Jurisdiction
CN
Classification
—
Expires
2022-12-20
Drug substance claim
No
Drug product claim
No
Assignee
Weihai Marine Biological Medicine Industry Technology Research Institute Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.